NEWS
Just
Published
New retrospective study in Obesity Surgery reports perioperative outcomes of the Titan SGS™ Stapler
Propensity matched retrospective review of 783 laparoscopic sleeve gastrectomies reports the perioperative outcomes of the Titan SGS™ Stapler as compared to multi-fire surgical staplers. The study results link the Titan SGS™ Stapler to potentially enhanced outcomes. The study was conducted by surgeons at Corewell Health Hospital in Grand Rapids, MI.
Dr. Schram and Dr. Foote, two of the authors of the study, are paid consultants of Teleflex Incorporated. Fritz, G.D., Sharrak, A., Aubrey, J. et al. Perioperative Outcomes Using Single-Fire Stapler. OBES SURG (2024). https://doi.org/10.1007/s11695-024-07357-4
Titan SGS® from Standard Bariatrics, Inc. Passes 1,000 Clinical Case Uses
Bariatric surgeons are seeing benefits delivered to patients from the anatomy-based approach of Titan SGS® surgical stapler technology from Standard Bariatrics®, Inc. Since the first use in gastric sleeve surgery on August 24, 2021, the Titan SGS has now been used in over 1,000 clinical cases and efficacy data continues to build.
Standard Bariatrics, Inc. Reaches Sales Milestone with Titan SGS®
Standard Bariatrics®, Inc. (SBI), a Cincinnati-based company focused on developing medical devices for surgical treatments of obesity, announced it reached a $1M sales milestone during November 2021 for the Titan SGS™, a surgical stapler first used in gastric sleeve surgery on August 24, 2021 following FDA clearance.
FDA Issues Updated Guidance on Surgical Staplers
This month, the US Food and Drug Administration (FDA) issued guidance on surgical staplers and staples for internal use. Learn more about the new Class II designation for surgical staplers, including the FDA’s recommendation for labeling regarding risks associated with staple line crossing. Titan SGS™ from Standard Bariatrics® was recently cleared by the FDA under the more stringent Class II guidelines.
Standard Bariatrics® Announces the First Use of Titan SGS™ in a Robotic Sleeve Gastrectomy
Bariatric surgeon Paul Enochs, MD, FACS, FASMBS, completed sleeve gastrectomy cases using Titan SGS™ for the first time in North Carolina. He shared his experience in using Titan SGS in a robotic approach to sleeve gastrectomy.
Standard Bariatrics® Announces the First Post-FDA-Clearance Use of Titan SGS™
Bariatric surgeon Aaron Hoffman, MD, FACS, this week completed the first procedures using Titan SGS™ following its clearance by the FDA in April 2021. Dr. Hoffman performed five cases. The Titan SGS was cleared for use after a multi-site, 62-patient IDE study in longitudinal gastric resection.
Standard Bariatrics® Earns FDA Clearance for Standard Bougie™ 38FR
Standard Bariatrics today announced US Food and Drug Administration (FDA) clearance for its Standard Bougie 38 FR, designed for use with the Titan SGS™ stapler and the bladeless technology of the Standard Trocar™. The Standard Bougie 38 FR allows bariatric surgeons to achieve precise anatomical alignment and protect the incisura angularis during sleeve pouch creating, helping ensure the best possible outcomes for gastric sleeve patients.